Muscle Energy Technique and Myofascial Chain Training for Menstrual Pain in Primary Dysmenorrhea (METPD-25)
NCT ID: NCT07058480
Last Updated: 2025-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2024-12-15
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Extracorporeal Shock Wave Therapy in the Treatment of Primary Dysmenorrhea
NCT03121170
The Efficacy of Myofascial Chain Release Techniques in Patients With Patellofemoral Pain Syndrome.
NCT05327569
Comparison of Acute Effects of Myofascial Release and Kinesio Taping® in Dysmenorrhea
NCT06925087
Effectiveness of Structured Myofascial Release
NCT06744608
Effectiveness of Self-myofascial Release Combined With Biofeedback and Electrical Stimulation for the Management of MFPP
NCT04746352
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This prospective non-randomized controlled trial investigates whether a combined intervention of muscle energy technique (MET) and myofascial chain (MFC)-based pelvic stabilization training can improve pelvic structure and reduce clinical symptoms in women with PD. Participants are women aged 18-45 years with moderate-to-severe PD and radiographic evidence of pelvic misalignment. They are assigned to one of two groups:
Experimental group: MET plus MFC-based core stabilization exercises. Control group: Interferential current therapy and deep friction massage. Interventions are administered three times per week for four weeks. The primary outcomes include changes in pelvic sagittal parameters (pelvic tilt, sacral slope, pelvic incidence), pelvic symmetry, menstrual pain (measured by VAS), and static balance (eyes-closed single-leg stance). Assessments are conducted at baseline, 4 weeks, and 12 weeks post-intervention.
The study aims to explore whether biomechanical correction of pelvic alignment contributes to pain modulation and functional improvement in women with PD, providing a basis for non-pharmacological rehabilitation strategies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Combined MET and MFC-Based Pelvic Stabilization
Participants receive Muscle Energy Technique (MET) for iliac dysfunction and sacral torsion, plus myofascial chain-based pelvic stabilization training (curl-ups, planks, anti-rotation). 3 sessions/week, 50 minutes/session, for 4 weeks.
Combined MET and MFC-Based Pelvic Stabilization Training
This intervention consisted of a combination of Muscle Energy Technique (MET) for iliac and sacral dysfunctions (20 minutes per session) and myofascial chain-based pelvic stabilization training (including curl-ups, planks, and anti-rotation exercises; 30 minutes per session), targeting pelvic alignment and neuromuscular control. Sessions were conducted 3 times per week, 50 minutes per session, for 4 consecutive weeks.
Interferential current therapy (ICT) and Deep Friction Massage (DFM)
Participants receive medium- and low-frequency electrotherapy and deep friction massage targeting the lumbar (lower back), sacroiliac, and iliac crest regions. 3 sessions/week, 50 minutes/session, for 4 weeks.
Interferential current therapy (ICT)
Interferential current therapy (ICT) was applied to the lumbar (lower back), sacroiliac, and iliac crest regions, 3 sessions per week, 20 minutes per session, for 4 weeks.
Deep Friction Massage (DFM)
Deep friction massage was administered to the lumbar, sacroiliac, and iliac crest regions for 30 minutes per session, 3 sessions per week, for 4 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Combined MET and MFC-Based Pelvic Stabilization Training
This intervention consisted of a combination of Muscle Energy Technique (MET) for iliac and sacral dysfunctions (20 minutes per session) and myofascial chain-based pelvic stabilization training (including curl-ups, planks, and anti-rotation exercises; 30 minutes per session), targeting pelvic alignment and neuromuscular control. Sessions were conducted 3 times per week, 50 minutes per session, for 4 consecutive weeks.
Interferential current therapy (ICT)
Interferential current therapy (ICT) was applied to the lumbar (lower back), sacroiliac, and iliac crest regions, 3 sessions per week, 20 minutes per session, for 4 weeks.
Deep Friction Massage (DFM)
Deep friction massage was administered to the lumbar, sacroiliac, and iliac crest regions for 30 minutes per session, 3 sessions per week, for 4 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Regular menstrual cycles
* Clinically diagnosed with primary dysmenorrhea
* Visual Analog Scale (VAS) score ≥ 4 during menstruation for at least six consecutive months
* Radiographic evidence of pelvic tilt, sacral slope deviation, or frontal pelvic asymmetry
Exclusion Criteria
* Pregnancy or lactation
* Current use of hormonal contraceptives or hormone therapy
* Ongoing or recent physical therapy targeting the pelvis
* History of pelvic or spinal surgery
* Congenital or structural musculoskeletal disorders affecting the lumbopelvic region
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanjiao Luo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shanjiao Luo
PhD Candidate / Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shanjiao Luo, PhD
Role: PRINCIPAL_INVESTIGATOR
Shenzhen JianAn Hospital / Sehan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shenzhen JianAn Hospital
Shenzhen, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gartenberg A, Nessim A, Cho W. Sacroiliac joint dysfunction: pathophysiology, diagnosis, and treatment. Eur Spine J. 2021 Oct;30(10):2936-2943. doi: 10.1007/s00586-021-06927-9. Epub 2021 Jul 16.
Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2014;36:104-13. doi: 10.1093/epirev/mxt009. Epub 2013 Nov 26.
Wang J, He X, Zhu C, Ding H, Feng G, Yang X, Liu L, Song Y. The relationship between spino-pelvic alignment and primary dysmenorrhea. Front Surg. 2023 Feb 8;10:1125520. doi: 10.3389/fsurg.2023.1125520. eCollection 2023.
Legaye J, Duval-Beaupere G, Hecquet J, Marty C. Pelvic incidence: a fundamental pelvic parameter for three-dimensional regulation of spinal sagittal curves. Eur Spine J. 1998;7(2):99-103. doi: 10.1007/s005860050038.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
Shenzhen JianAn Hospital official website, the clinical trial site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JAH-METPD-2025-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.